Moderna

Moderna Inc. (NASDAQ: MRNA) is a biotechnology company pioneering messenger RNA therapeutics and vaccines, having risen to global prominence through the development of one of the first authorized COVID-19 vaccines, Spikevax, which generated tens of billions in revenue and validated the mRNA platform. Beyond COVID-19, the company is advancing a broad pipeline of mRNA-based candidates targeting respiratory syncytial virus, influenza, cancer, rare diseases, and autoimmune conditions, leveraging ...

Threads